BLAUVELT, A.; STEIN GOLD, L.; GOODERHAM, M.; STROBER, B.; PINTER, A.; CARRASCOSA, J.-M.; GISONDI, P.; BLEIER, J.; MADDEN, C.; DEHERDER, D.; GOMEZ, N. N.; WARREN, R. B. Bimekizumab efficacy and safety through two years in patients with moderate psoriasis: Analysis of pooled data from five phase 3/3b clinical trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 6, p. s67, 2022. DOI: 10.25251/skin.6.supp.67. Disponível em: https://jofskin.org/index.php/skin/article/view/1822. Acesso em: 19 jul. 2024.